Income Taxes (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
| Income Tax Disclosure [Abstract] |
|
| Schedule of US and Foreign Component of Income (Loss) Before Income Tax |
The U.S. and foreign components of income (loss) before provision for (benefit from) income taxes for the years ended December 31, 2023, 2024, and 2025 are as follows (in millions): | | | | | | | | | | | | | | | | | | | | | | | Year Ended December 31, | | | 2023 | | 2024 | | 2025 | | U.S. | | $ | 1,525 | | | $ | 3,455 | | | $ | 4,620 | | | Foreign | | 796 | | | 670 | | | 1,180 | | | Income before income taxes and income (loss) from equity method investments | | $ | 2,321 | | | $ | 4,125 | | | $ | 5,800 | |
|
| Schedule of Components of Income Tax Expense |
The components of the provision for (benefit from) income taxes for the years ended December 31, 2023, 2024, and 2025 are as follows (in millions): | | | | | | | | | | | | | | | | | | | | | | | Year Ended December 31, | | | 2023 | | 2024 | | 2025 | | Current | | | | | | | | Federal | | $ | 1 | | | $ | 22 | | | $ | 164 | | | State | | 16 | | | 42 | | | 116 | | | Foreign | | 170 | | | 205 | | | 153 | | | Total current tax expense | | 187 | | | 269 | | | 433 | | | Deferred | | | | | | | | Federal | | 11 | | | (5,154) | | | (118) | | | State | | 12 | | | (857) | | | 98 | | | Foreign | | 3 | | | (16) | | | (4,759) | | | Total deferred tax expense (benefit) | | 26 | | | (6,027) | | | (4,779) | | | Total provision for (benefit from) income taxes | | $ | 213 | | | $ | (5,758) | | | $ | (4,346) | |
|
| Schedule of Reconciliation of the Statutory Federal Income Tax Rate |
The following is a reconciliation of the statutory federal income tax rate to our effective tax rate for the years ended December 31, 2023 and 2024: | | | | | | | | | | | | | | | | | | | Year Ended December 31, | | | 2023 | | 2024 | | | | Federal statutory income tax rate | | 21.0 | % | | 21.0 | % | | | State income tax expense (1) | | 1.2 | | | (19.8) | | | | | Foreign rate differential | | (0.4) | | | (0.4) | | | |
| | | | | | | | | | | | | | | | | | Non-deductible expenses | | (0.2) | | | 2.2 | | | | | Stock-based compensation | | (1.9) | | | (5.2) | | | | | Federal research and development credits | | (7.2) | | | (5.1) | | | | Deferred tax on investments | | (3.5) | | | — | | | | Entity restructuring | | 0.6 | | | (0.5) | | | | Change in unrecognized tax benefits | | (6.8) | | | 37.8 | | | | Valuation allowance (2) | | (2.8) | | | (164.3) | | | | | US effects on foreign operations | | 4.1 | | | (2.5) | | | | | Withholding taxes | | 9.5 | | | (0.1) | | | | | Other interest | | (4.1) | | | (2.8) | | | | | Other, net | | (0.3) | | | 0.1 | | | | | Effective income tax rate | | 9.2 | % | | (139.6) | % | | |
(1) We reported the effects of the state valuation allowance on the state income tax expense line-item within our effective tax rate. In 2024, we released $1.2 billion of our valuation allowance on our U.S. state deferred tax assets, with the exception of our California R&D credits. (2) In 2024, we released $5.2 billion of our valuation allowance on our U.S. federal deferred tax assets. This was included on the change in valuation allowance line-item. The following is a reconciliation of the statutory federal income tax rate to our effective tax rate for the years ended December 31, 2025 (in millions): | | | | | | | | | | | | | | | | | Year Ended December 31, 2025 | | | | | Federal statutory income tax rate | | $ | 1,218 | | | 21.0 | % | State and local income taxes, net of federal income tax effect (1) | | 156 | | | 2.7 | | | Federal | | | | | | Changes in valuation allowances | | (14) | | | (0.2) | | | Effect of cross-border tax laws | | | | | | Foreign-derived intangible income | | (73) | | | (1.3) | | | Global intangible low-taxed income | | 107 | | | 1.8 | | | Other | | 26 | | | 0.4 | | | Tax credits | | | | | | Foreign tax credits | | (173) | | | (3.0) | | | Research and development credits | | (55) | | | (0.9) | | | Other | | (2) | | | — | | | Nontaxable or nondeductible items | | | | | | Excess tax benefits on share-based payments | | (216) | | | (3.7) | | | Stock based compensation | | 90 | | | 1.6 | | | Other | | 31 | | | 0.5 | | | Other adjustments | | | | | | Capitalized research and development expenses | | (338) | | | (5.8) | | | Loss on subsidiary stock | | (620) | | | (10.7) | | | Capital loss on debt instrument | | (285) | | | (4.9) | | | Other | | (34) | | | (0.6) | | | Foreign tax effects | | | | | | Netherlands | | | | | Changes in valuation allowances(2) | | (5,011) | | | (86.4) | | | Other | | 74 | | | 1.3 | | | Brazil | | | | | | Withholding tax expense | | 128 | | | 2.2 | |
| | | | | | | | | | | | | | | | Other | | (2) | | | — | | | India | | | | | | Changes in valuation allowances | | 88 | | | 1.5 | | | Other | | (47) | | | (0.8) | | | Other foreign jurisdictions | | 16 | | | 0.3 | | | Worldwide changes in unrecognized tax benefits | | 590 | | | 10.2 | | | Effective income tax rate | | $ | (4,346) | | | (74.8) | % |
(1) In 2025, the states that contributed to the majority (greater than 50%) of the tax effect in this category are Florida, Illinois, and New Jersey. (2) In 2025, we released $5.0 billion of our valuation allowance on our Netherlands' deferred tax assets.
|
| Schedule of Income Taxes Paid |
The following is the cash paid for income taxes for the year ended December 31, 2025 (in millions): | | | | | | | | | | | Year Ended December 31, 2025 | | | | | | | | US federal | | $ | 12 | | | US state and local | | 81 | | | Foreign | | 252 | | | Total income taxes paid, net of refunds | | $ | 345 | |
|
| Schedule of Deferred Tax Assets and Liabilities |
The components of deferred tax assets and liabilities as of December 31, 2024 and 2025 are as follows (in millions): | | | | | | | | | | | | | | | | | As of December 31, | | | 2024 | | 2025 | | Deferred tax assets | | | | | | Net operating loss carryforwards | | $ | 4,319 | | | $ | 3,177 | | | Research and development credits | | 1,539 | | | 1,641 | | | Stock-based compensation | | 71 | | | 122 | | | Accruals and reserves | | 730 | | | 1,297 | | | Accrued legal | | 221 | | | 234 | | Fixed assets and intangible assets (1) | | 3,226 | | | 2,938 | | | Lease liability | | 391 | | | 367 | | | Interest limitation carryforwards | | 760 | | | 657 | | Capitalized research expenses (1) | | 1,591 | | | 2,175 | | | Other | | 381 | | | 307 | | | Total deferred tax assets | | 13,229 | | | 12,915 | | | Less: Valuation allowance | | (6,267) | | | (1,312) | | | Total deferred tax assets, net of valuation allowance | | 6,962 | | | 11,603 | | | Deferred tax liabilities | | | | | | Investments | | 515 | | | 418 | | | Right-of-use assets | | 270 | | | 253 | | | Other | | 14 | | | 9 | | | Total deferred tax liabilities | | 799 | | | 680 | | | Net deferred tax assets (liabilities) | | $ | 6,163 | | | $ | 10,923 | |
(1) Prior period amounts have been reclassified to conform to the current period presentation. Certain deferred tax assets in Fixed Assets and Intangibles were reclassified to Capitalized Research Expenses.
|
| Schedule of Unrecognized Tax Benefits Roll Forward |
The following table reflects changes in gross unrecognized tax benefits (in millions): | | | | | | | | | | | | | | | | | | | | | | | Year Ended December 31, | | | 2023 | | 2024 | | 2025 | | Unrecognized tax benefits at beginning of year | | $ | 3,513 | | | $ | 3,345 | | | $ | 4,937 | | | Gross increases - current year tax positions | | 177 | | | 201 | | | 693 | | Gross increases - prior year tax positions (1) | | 42 | | | 1,437 | | | 13 | | | Gross decreases - prior year tax positions | | (315) | | | (37) | | | (26) | | | Gross decreases - settlements with tax authorities | | — | | | (6) | | | (5) | | | Gross decreases - lapse of statute of limitations | | (72) | | | (3) | | | (1) | | | Unrecognized tax benefits at end of year | | $ | 3,345 | | | $ | 4,937 | | | $ | 5,611 | |
(1) In 2024, new information became available that required a remeasurement of a prior year transfer pricing tax position resulting in an overall reduction in our net deferred tax assets of $1.2 billion, which was fully offset by a change in the valuation allowance. This is reflected in the increases to prior year uncertain tax positions above.
|
| Schedule of Open Tax Years for Major Tax Jurisdictions |
As of December 31, 2025, the open tax years for our major tax jurisdictions are as follows: | | | | | | | | | | Jurisdiction | | Tax Years | | U.S. Federal | | 2013 - 2025 | | U.S. States | | 2007 - 2025 | | Australia | | 2019 - 2025 | | Netherlands | | 2019 - 2025 | | United Kingdom | | 2022 - 2025 |
|